×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
[V2-S3] How Can We Apply the Electric Health Records for Postmarketing Drug Safety in Japan?
Session Chair(s)
Kiyoshi Kubota, MD, PhD, FISPE
Director
Drug Safety Research Unit Japan, Japan
Chieko Ishiguro, PhD, MPH
Section Chief of Clinical Epidemiology, Department of Data Science
National Center for Global Health and Medicine, Japan
Speaker(s)
How can we apply the electric health records for Post-Marketing Safety Measures-MIHARI Project & MID-NET-
Maki Komamine
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Pharmacoepidemiologist
Remarks from the Academic Viewpoint
Takuhiro Yamaguchi, PhD
Tohoku University Graduate School of Medicine, Japan
Professor, Biostatistics
Thoughts from a pharmaceutical industry perspective
Kotonari Aoki, MS
Chugai Pharmaceutical Co., Ltd., Japan
Head of Real World Data Science Dept. Drug Safety Div.
TheParadigmwithout Japanese style Post-marketing Surveillance (PMS)
Tatsuo Kagimura, MPH
Translational Research Informatics Center (TRI), Japan
Chief, Department of Analysis
Have an account?